Oncolix Inc. (fka ONCX)

[DayDreeming]

Oncolix incurring more costs and doing nothing in the way of research and development of Prolanta per 10Q dated June 30th:

"The Company incurred no revenues or research and development expenses during the six months ended June 30, 2017 and 2016. General and administrative expenses increased by $57,926 between the periods, principally as a result of the costs related to the management of activities by Oncolix (Delaware) and costs associated with the Merger. Oncolix (Delaware) changed $25,924 for compensation costs and $2,000 for occupancy costs to manage the activities of the Company during the three months ended June 30, 2017. In addition, the Company incurred approximately $29,000 in legal expenses in connection with the proposed Merger with Oncolix (Delaware) in the 2017 period. The costs paid by Oncolix (Delaware) ($approximately $52,000) are reflected as a liability of the Company as of June 30, 2017."

Source:
10Q page 18
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12314035